GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » TOWA Pharmaceutical Co Ltd (OTCPK:TWAPF) » Definitions » Quick Ratio

TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Quick Ratio : 1.48 (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is TOWA Pharmaceutical Co Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. TOWA Pharmaceutical Co's quick ratio for the quarter that ended in Dec. 2023 was 1.48.

TOWA Pharmaceutical Co has a quick ratio of 1.48. It generally indicates good short-term financial strength.

The historical rank and industry rank for TOWA Pharmaceutical Co's Quick Ratio or its related term are showing as below:

TWAPF' s Quick Ratio Range Over the Past 10 Years
Min: 0.82   Med: 1.41   Max: 1.89
Current: 1.46

During the past 13 years, TOWA Pharmaceutical Co's highest Quick Ratio was 1.89. The lowest was 0.82. And the median was 1.41.

TWAPF's Quick Ratio is ranked better than
54.66% of 1072 companies
in the Drug Manufacturers industry
Industry Median: 1.32 vs TWAPF: 1.46

TOWA Pharmaceutical Co Quick Ratio Historical Data

The historical data trend for TOWA Pharmaceutical Co's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOWA Pharmaceutical Co Quick Ratio Chart

TOWA Pharmaceutical Co Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Quick Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.00 1.48 0.82 1.15 1.46

TOWA Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.15 1.36 1.42 1.48 1.46

Competitive Comparison of TOWA Pharmaceutical Co's Quick Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, TOWA Pharmaceutical Co's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


TOWA Pharmaceutical Co's Quick Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, TOWA Pharmaceutical Co's Quick Ratio distribution charts can be found below:

* The bar in red indicates where TOWA Pharmaceutical Co's Quick Ratio falls into.



TOWA Pharmaceutical Co Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

TOWA Pharmaceutical Co's Quick Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Quick Ratio (A: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1453.211-674.629)/534.767
=1.46

TOWA Pharmaceutical Co's Quick Ratio for the quarter that ended in Dec. 2023 is calculated as

Quick Ratio (Q: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(1480.676-692.221)/534.478
=1.48

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TOWA Pharmaceutical Co  (OTCPK:TWAPF) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


TOWA Pharmaceutical Co Quick Ratio Related Terms

Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
2-11, Shinbashi-cho, Kadoma, Osaka, JPN, 571-8580
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.

TOWA Pharmaceutical Co (TOWA Pharmaceutical Co) Headlines

No Headlines